Skip to main content
TipRanks
Go Ultimate75% OFF

Angela Frances Holtham Insider Profile

18 Followers

Angela Frances Holtham, Director at Oncolytics Biotech, holds 183.64K shares in Oncolytics Biotech (Ticker: ONCY), holds 1.30K shares in Jamieson Wellness Inc (Ticker: TSE:JWEL), holds 4.80K shares in IBI Group (Ticker: IBIBF).

Angela Frances Holtham's Trading History

JWEL
Jamieson Wellness Inc
Mar 05, 2019DirectorInformative Buy15.72KC$59.42K
IBIBF
IBI Group
Dec 22, 2015―Informative Buy10.08K$68.62K
ONCY
Oncolytics Biotech
―Director―$62.25K

You May Also Like

Angela Frances Holtham insider profile FAQ

What is the percentage of profitable transactions made by Angela Frances Holtham?
The percentage of profitable transactions made by Angela Frances Holtham is 100%.
What is the average return per transaction made by Angela Frances Holtham?
The average return per transaction made by Angela Frances Holtham is 72.20%.
What stocks does Angela Frances Holtham hold?
Angela Frances Holtham holds: ONCY, IBIBF, TSE:JWEL stocks.
What was Angela Frances Holtham's most profitable transaction?
Angela Frances Holtham’s most profitable transaction was an Informative Buy of IBIBF stock on December 22, 2015. The return on the trade was 133.30%.
What is Angela Frances Holtham's role in Oncolytics Biotech?
Angela Frances Holtham's role in Oncolytics Biotech is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.